Bay­er, GSK, No­var­tis and Roche jump­start bio­mark­er can­cer or­ga­ni­za­tion to dri­ve tests for all

A hand­ful of promi­nent on­col­o­gy phar­mas are team­ing up on a next-gen di­ag­nos­tics ini­tia­tive, with the am­bi­tious vi­sion of test­ing for all can­cer pa­tients. Bay­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER